Brain MRI checks to prevent lung cancer brain symptoms
Treatments studied
Part of Brain & nervous system, Cancer, Lungs & breathing clinical trials.
This trial tests whether doing scheduled brain MRI scans can lower the chance that lung cancer later causes symptomatic brain metastases (tumors that cause symptoms in the brain). If you’re eligible, you’ll get brain MRI surveillance at a specific time after starting radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 or older
- You have stage IIIA, IIIB, or IIIC lung cancer that is not squamous-only (with specific allowed cell types)
- Your first brain MRI scan must happen about 120 days after your first radiation treatment (between 110 and 130 days)
- You do not already have known brain metastases on the baseline staging MRI
- You can safely have an MRI based on MRI safety screening
- You are not pregnant or breastfeeding (and pregnancy testing is required if applicable)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a specific kind of MRI picture (called the CEST sequence) can help characterize radiation-related brain injury and changes in brain metastases from lung cancer. It may help doctors better interpret follow-up scans after radiation, without changing your cancer treatment.
This trial uses brain MRI scans and deep learning to predict whether non-small cell lung cancer that has spread to the brain has certain gene changes (EGFR or ALK). Knowing this may help guide treatment without needing additional tissue testing.
This study tests a special MRI technique to better distinguish between tumor regrowth and radiation-related changes in people with brain tumors. If you've had radiation for a brain tumor and now have suspicious changes, this scan might help guide your next steps.
This trial looks at whether doing an MRI scan of the brain for people with stage IV lung cancer helps in their care. The goal is to find brain issues early (if present) so treatment decisions can be made sooner.
This trial tests whether regular brain MRI scans can help detect brain metastases early in patients with stage IV breast cancer who do not yet have any known brain metastases. The goal is to see if early detection improves outcomes.
This trial uses regular MRI scans to screen for brain metastases in people with certain advanced cancers (HER2-positive or triple-negative breast cancer, non-small cell lung cancer, or melanoma). The goal is to detect brain spread early, which may help guide treatment and improve outcomes.
Hear when a new Brain Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.